Skip to content

Reduction of stress and prevention of metabolic syndrome through music and laugh: randomized-controlled trial

Reduction of stress and prevention of metabolic syndrome through music and laugh: randomized-controlled trial - Reduction of stress and prevention of metabolic syndrome through music and laugh: randomized-controlled trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000005364
Enrollment
200
Registered
2011-04-01
Start date
2009-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

normal to high blood pressure

Interventions

Health Education and Music Intervention Music Intervention: Conducted mainly by two music therapists. The sessions were composed of listening to, singing and stretching with music. Participants wer
s stimulated through playful eye contact, and watched Rakugo, Japanese traditional sit-down comedy. Participants were also encouraged to do laughter yoga at home. Healhty Education Only

Sponsors

Public Health, Osaka University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: no critical disease and possible to participate intervention.

Exclusion criteria

Exclusion criteria: have critical disease and impossible to participate in intervention.

Design outcomes

Primary

MeasureTime frame
blood pressure, heart rate, and coltisol

Secondary

MeasureTime frame
perceived stress, lifestyle behaviors (diet, exercize, alcohol intake, sleep duration etc.) hours of listening music and laughter at home, Augmentation index, biochemical examination, peripheral blood examination, hemoglobin A1c and immunological test

Countries

Japan

Contacts

Public ContactEri Eguchi

Osaka University Graduate School of Medicine Public Health

06-6879-3911

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026